Tofacitinib
Showing 1 - 25 of 215
Glioblastoma Trial (Tofacitinib 5 MG)
Not yet recruiting
- Glioblastoma
- Tofacitinib 5 MG
- (no location specified)
Jul 1, 2022
Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)
Completed
- Sarcoidosis, Pulmonary
- +2 more
- Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
- +5 more
-
Portland, OregonOregon Health & Science University
Dec 3, 2021
Alopecia Areata Trial in Bangkok (Tofacitinib)
Completed
- Alopecia Areata
- Tofacitinib
-
Bangkok, ThailandInstitute of Dermatology
Mar 28, 2022
Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)
Not yet recruiting
- Vitiligo
- Effect of Drug
- JAK-2 inhibitor
- Topical corticosteroid
- (no location specified)
Mar 19, 2022
Healthy Subjects Trial in Québec (Tofacitinib Citrate)
Completed
- Healthy Subjects
- Tofacitinib Citrate
-
Québec, CanadaSyneos Health Facility
Nov 25, 2021
Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Interstitial Lung Disease
- Tofacitinib
-
Mexico City, Tlalpan, MexicoInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
Apr 4, 2022
Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy
Recruiting
- Ulcerative Colitis
- Spondyloarthropathy
- Tofacitinib
-
Palermo, ItalyIBD Unit, Department of Internal Medicine, "Villa Sofia-Cervello
Jun 21, 2022
Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus
- Tofacitinib
-
Ann Arbor, MichiganUniversity of Michigan Health System: Department of Internal Med
May 2, 2022
Atopic Dermatitis Trial (Tofacitinib Citrate, ointment)
Not yet recruiting
- Atopic Dermatitis
- Tofacitinib Citrate
- placebo ointment
- (no location specified)
Aug 2, 2022
Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)
Recruiting
- Primary Sjögren's Syndrome
- Tofacitinib
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)
Recruiting
- Immune-Mediated Colitis
- Tofacitinib 10 mg
-
Montreal, Quebec, CanadaSir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022
COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)
Terminated
- COVID-19 Pneumonia
- Tofacitinib 10 mg
- Placebo
-
New Haven, ConnecticutYale New Haven Health System
Mar 16, 2022
TNFi as Monotherapy or Combination Therapy With MTX and Compare
Completed
- Rheumatoid Arthritis
- patterns of use of combination therapy and monotherapy
-
New York, New YorkPfizer
Oct 7, 2022
Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)
Recruiting
- Sjogren's Syndrome
- tofacitinib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Tofacitinib After Use Of Rituximab In Rheumatoid Arthritis In A
Not yet recruiting
- Arthritis, Rheumatoid
-
Casablanca, MoroccoPfizer
Aug 2, 2022
Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)
Terminated
- Discoid Lupus Erythematosus
- Systemic Lupus Erythematosus
- Tofacitinib citrate
-
Boston, MassachusettsTufts Medical Center
Jan 6, 2022
Tofacitinib PsA Initiators in the CorEvitas SpA Registry
Active, not recruiting
- Psoriatic Arthritis
-
New York, New YorkPfizer
Feb 8, 2022
Tofacitinib on Body Composition, Bone Mineral Density and Bone
Suspended
- Rheumatoid Arthritis
- Tofacitinib
-
Lille, FranceLille University Hospital
Feb 7, 2022
Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Takayasu Arteritis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaLindi Jiang
Oct 19, 2021
Finland Treated With Tofacitinib for Treatment of Ulcerative
Active, not recruiting
- Ulcerative Colitis
-
Helsinki, FinlandPfizer
Jul 10, 2022
ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)
Completed
- ANCA Associated Vasculitis
- +2 more
- Tofacitinib
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 20, 2021
Ulcerative Colitis Trial in Chapel Hill
Enrolling by invitation
- Ulcerative Colitis
-
Chapel Hill, North CarolinaDivision of Gastroenterology and Hepatology
Feb 21, 2022
Myasthenia Gravis, Generalized Trial in Shanghai (Tofacitinib 5 MG)
Recruiting
- Myasthenia Gravis, Generalized
- Tofacitinib 5 MG
-
Shanghai, ChinaHuashan Hospital
Aug 15, 2021